Vivid iq

The GE Vivid iq is a compact, high-performance diagnostic ultrasound system primarily intended for a wide range of clinical applications, including cardiovascular and shared services imaging. It achieves substantial equivalence to predicate devices by leveraging advanced ultrasonic imaging modes, new transducers, and enhanced software features, validated through non-clinical safety and performance testing.

GE Medical Systems Ultrasound and Primary Care Diagnostics, LLC has successfully obtained a determination of substantial equivalence for its Vivid iq device, enabling its market release. This diagnostic ultrasound system, classified as a Class II medical device, operates as an Ultrasonic Pulsed Doppler Imaging System and incorporates ultrasonic pulsed echo imaging and diagnostic ultrasound transducers. The company was notified that the Vivid iq is considered substantially equivalent to existing legally marketed predicate devices, confirming its compliance with necessary regulatory standards.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific improvements does Clarity+ image processing offer in terms of diagnostic accuracy or image clarity for challenging cardiovascular cases compared to previous versions?; How do the newly compatible ultrasound catheters and expanded vascular access indications enhance patient safety or procedural efficiency during interventional guidance?; What are the long-term data management implications of using DICOM Encapsulated PDF reporting, particularly regarding interoperability with existing hospital information systems?; Are there any specific scenarios or patient populations where the Vivid iq's compact size or extended battery life would provide a significant clinical advantage?; What non-clinical test methodologies were employed to confirm compliance with safety and performance standards for the expanded indications, given that clinical studies were not required?